{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:08:53Z","timestamp":1791493733541,"version":"4.3.4"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0233460","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T13:49:24Z","timestamp":1590155364000},"page":"e0233460","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cornea verticillata and acroparesthesia efficiently discriminate clusters of severity in Fabry disease"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4463-9757","authenticated-orcid":true,"given":"Wladimir","family":"Mauhin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Benveniste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Amelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Montagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foudil","family":"Lamari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Caillaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Douillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Dussol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Leguy-Seguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"D'Halluin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Noel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Zenone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Matignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Maillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim-Heang","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Besson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolaine","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Labombarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"Masseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lavigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Maillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lidove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,5,22]]},"reference":[{"key":"pone.0233460.ref001","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry\u2019s disease. Ceramidetrihexosidase deficiency","volume":"276","author":"RO Brady","year":"1967","journal-title":"N Engl J Med"},{"key":"pone.0233460.ref002","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/jmedgenet-2014-102872","article-title":"Poorthuis BJHM. Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease","volume":"52","author":"BE Smid","year":"2015","journal-title":"J Med Genet"},{"key":"pone.0233460.ref003","doi-asserted-by":"crossref","first-page":"e57631","DOI":"10.1371\/journal.pone.0057631","article-title":"Migalastat HCl reduces globotriaosylsphingosine (lyso-Gb3) in Fabry transgenic mice and in the plasma of Fabry patients","volume":"8","author":"B Young-Gqamana","year":"2013","journal-title":"PloS One"},{"key":"pone.0233460.ref004","first-page":"2102","article-title":"Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy","volume":"24","author":"R Schiffmann","year":"2009","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc\u2014Eur Ren Assoc"},{"key":"pone.0233460.ref005","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"PJ Meikle","year":"1999","journal-title":"JAMA"},{"key":"pone.0233460.ref006","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","article-title":"The frequency of lysosomal storage diseases in The Netherlands","volume":"105","author":"BJ Poorthuis","year":"1999","journal-title":"Hum Genet"},{"key":"pone.0233460.ref007","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset fabry disease revealed by newborn screening","volume":"79","author":"M Spada","year":"2006","journal-title":"Am J Hum Genet"},{"key":"pone.0233460.ref008","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jpeds.2017.06.048","article-title":"Newborn Screening for Lysosomal Storage Disorders in Illinois: The Initial 15-Month Experience","volume":"190","author":"BK Burton","year":"2017","journal-title":"J Pediatr"},{"key":"pone.0233460.ref009","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jamapediatrics.2018.0263","article-title":"Incidence of 4 Lysosomal Storage Disorders From 4 Years of Newborn Screening","volume":"172","author":"PV Hopkins","year":"2018","journal-title":"JAMA Pediatr"},{"key":"pone.0233460.ref010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/8904_2012_130","article-title":"Newborn screening for lysosomal storage disorders in hungary","volume":"6","author":"J Wittmann","year":"2012","journal-title":"JIMD Rep"},{"key":"pone.0233460.ref011","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJM199102073240607","article-title":"An atypical variant of Fabry\u2019s disease with manifestations confined to the myocardium","volume":"324","author":"W von Scheidt","year":"1991","journal-title":"N Engl J Med"},{"key":"pone.0233460.ref012","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2016090964","article-title":"Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study","volume":"28","author":"M Arends","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"pone.0233460.ref013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmedgenet-2013-101857","article-title":"A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance","volume":"51","author":"L van der Tol","year":"2014","journal-title":"J Med Genet"},{"key":"pone.0233460.ref014","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","article-title":"Fabry disease revisited: Management and treatment recommendations for adult patients","volume":"123","author":"A Ortiz","year":"2018","journal-title":"Mol Genet Metab"},{"key":"pone.0233460.ref015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122010","article-title":"The Large Phenotypic Spectrum of Fabry Disease Requires Graduated Diagnosis and Personalized Therapy: A Meta-Analysis Can Help to Differentiate Missense Mutations","volume":"17","author":"V Citro","year":"2016","journal-title":"Int J Mol Sci"},{"key":"pone.0233460.ref016","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000448968","article-title":"Long Term Treatment with Enzyme Replacement Therapy in Patients with Fabry Disease","volume":"134","author":"D Oder","year":"2016","journal-title":"Nephron"},{"key":"pone.0233460.ref017","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/M18-2478","article-title":"Association Between Dietary Supplement Use, Nutrient Intake, and Mortality Among US Adults: A Cohort Study","volume":"170","author":"F Chen","year":"2019","journal-title":"Ann Intern Med"},{"key":"pone.0233460.ref018","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1681\/ASN.2016060666","article-title":"Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment","volume":"28","author":"L Tonneijck","year":"2017","journal-title":"J Am Soc Nephrol JASN"},{"key":"pone.0233460.ref019","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-0004.2004.00219.x","article-title":"The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy","volume":"65","author":"C Whybra","year":"2004","journal-title":"Clin Genet"},{"key":"pone.0233460.ref020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13023-018-0877-4","article-title":"Deep characterization of the anti-drug antibodies developed in Fabry disease patients, a prospective analysis from the French multicenter cohort FFABRY","volume":"13","author":"W Mauhin","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"pone.0233460.ref021","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Y Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"pone.0233460.ref022","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000369309","article-title":"Foot process effacement is an early marker of nephropathy in young classic Fabry patients without albuminuria","volume":"129","author":"C T\u00f8ndel","year":"2015","journal-title":"Nephron"},{"key":"pone.0233460.ref023","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000493469","article-title":"Glomerular Hyperfiltration: An Early Marker of Nephropathy in Fabry Disease","volume":"141","author":"E Riccio","year":"2019","journal-title":"Nephron"},{"key":"pone.0233460.ref024","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy","volume":"121","author":"AJ Marian","year":"2017","journal-title":"Circ Res"},{"key":"pone.0233460.ref025","first-page":"f153","article-title":"Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice","volume":"20","author":"S Baig","year":"2018","journal-title":"Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol"},{"key":"pone.0233460.ref026","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jmg.2008.065904","article-title":"Natural course of Fabry disease: changing pattern of causes of death in FOS\u2014Fabry Outcome Survey","volume":"46","author":"A Mehta","year":"2009","journal-title":"J Med Genet"},{"key":"pone.0233460.ref027","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Authors\/Task Force members","year":"2014","journal-title":"Eur Heart J"},{"key":"pone.0233460.ref028","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/bjophthalmol-2014-306433","article-title":"Cornea verticillata supports a diagnosis of Fabry disease in non-classical phenotypes: results from the Dutch cohort and a systematic review","volume":"100","author":"L van der Tol","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"pone.0233460.ref029","article-title":"Cornea verticillata in Fabry disease: a comparative study between slit-lamp examination and in vivo corneal confocal microscopy","author":"A Leonardi","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"pone.0233460.ref030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cge.12613","article-title":"X-chromosome inactivation in female patients with Fabry disease","volume":"89","author":"L Echevarria","year":"2016","journal-title":"Clin Genet"},{"key":"pone.0233460.ref031","unstructured":"Prominent regression of corneal deposits in Fabry disease 16 years after initiation of enzyme replacement therapy.\u2014PubMed\u2014NCBI. [cited 27 Nov 2019]. Available: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Prominent+regression+ofcorneal+deposits+in+Fabrydisease+16+years+afterinitiation+of+enzymereplacement+therapy"},{"key":"pone.0233460.ref032","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/jmedgenet-2011-100407","article-title":"Fabry International Prognostic Index: a predictive severity score for Anderson-Fabry disease","volume":"49","author":"DA Hughes","year":"2012","journal-title":"J Med Genet"},{"key":"pone.0233460.ref033","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/ckj\/sfy126","article-title":"Will the FAbry STabilization indEX make its way to everyday clinical practice?","volume":"12","author":"T Cairns","year":"2019","journal-title":"Clin Kidney J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0233460","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T13:49:43Z","timestamp":1590155383000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0233460"}},"subtitle":[],"editor":[{"given":"Maria Vittoria","family":"Cubellis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,5,22]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0233460","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,22]]}}}